Related Experiment Video

Updated: Jul 18, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
07:38

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s

Published on: September 25, 2017

Oxidative detoxication of carcinogenic 2-nitroanisole by human, rat and rabbit cytochrome P450

Helena Dracínska1, Markéta Miksanová, Martina Svobodová

  • 1Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.

Neuro Endocrinology Letters
|December 13, 2006
PubMed
Abstract

Insights

This study investigated the metabolism of 2-nitroanisole (2-NA) in humans, rats, and rabbits. Findings show that rats and rabbits can serve as suitable models for understanding 2-NA oxidation in humans.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Cytochromes P450 (P450) are crucial enzymes in xenobiotic metabolism.
  • Understanding species-specific P450 activity is vital for accurate risk assessment of chemical carcinogens.
  • 2-nitroanisole (2-NA) is a potent rodent carcinogen whose metabolic pathways require detailed investigation.

Purpose of the Study:

  • To investigate the detoxifying metabolism of 2-nitroanisole (2-NA) by human, rabbit, and rat cytochromes P450 (P450).
  • To compare the metabolic profiles across species to assess the suitability of animal models for human health risk extrapolation.
  • To identify the specific P450 enzymes involved in 2-NA metabolism.

Main Methods:

  • High-performance liquid chromatography (HPLC) with UV detection was used for metabolite separation and characterization.
  • Metabolites were analyzed from hepatic microsomes, human recombinant P450s, and purified P450s from rats and rabbits.
  • Enzyme kinetics and metabolite identification were performed to elucidate metabolic pathways.

Main Results:

  • 2-nitroanisole (2-NA) was metabolized to 2-nitrophenol (2-NP), 2,5-dihydroxynitrobenzene (2,5-DNB), and 2,6-dihydroxynitrobenzene (2,6-DNB) across all species studied.
  • Human microsomes predominantly produced 2,5-DNB, while rabbit and rat microsomes yielded 2-NP as the major metabolite.
  • Human P450 2E1 was identified as a key enzyme in 2-NA oxidation in human hepatic microsomes, with orthologous animal P450s also showing significant activity.

Conclusions:

  • Orthologous P450 enzymes play a conserved role in 2-nitroanisole (2-NA) oxidation across humans, rats, and rabbits.
  • The metabolic profiles suggest that rat and rabbit models can effectively mimic 2-NA oxidation pathways observed in humans.
  • These findings support the use of rat and rabbit models for extrapolating carcinogenicity data and assessing human health risks associated with 2-NA exposure.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter12:15

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter

Published on: May 29, 2019

Related Concept Videos

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...